Medtide Inc. (Stock Code: 03380.HK) is a peptide-focused contract research, development, and manufacturing organization (CRDMO), offering full-cycle services ranging from early-stage discovery, pre-clinical research and clinical development to commercial-stage production. The company is headquartered in Hangzhou, China, and has commercial production bases and offices in both China and the United States. We have been deeply involved in the peptide field for over 20 years. Today, we have become a CRDMO with global operations and comprehensive service capabilities.

Medtide Inc. provides (i) contract research organization (CRO) services,namely peptide new chemical entity (NCE) discovery synthesis; and (ii) contract development and manufacturing organization (CDMO) services,namely peptide chemistry, manufacturing and controls (CMC) development and commercial manufacturing. We have established global operations, with projects covering over 50 countries, including major markets such as China, the United States, Japan, Europe, South Korea, and Australia. We provide our 1000+ customers with peptide drug development, production, and CMC documentation and filing support services that meet regulatory requirements in major markets worldwide.

We have a team of experts dedicated to the research and production of peptides and oligonucleotides, possessing extensive professional knowledge and project experience. We are capable of meeting production needs ranging from simple to complex and challenging molecules. Whether in technical capabilities or project management, we can meet customer requirements and provide high-quality, reliable services. Through rigorous quality control system, rapid production speed, extensive overall and per-batch production capacity, we formed a wide range of advantages, creating a high entry barrier for our services.We have a diversified customer base, with customers located in North America, Asia, Europe and other countries. In addition to large pharmaceutical and biotech companies, we provide comprehensive and customized services responding to the needs of a growing group of diverse biotech start-ups and virtual pharmaceutical and biotech companies. We are devoted to enhancing the breadth of our services and providing customized services to target customers with unique needs and demands.

As a trusted and sustainable enterprise, Medtide Inc. has established long-term partnerships with many customers. Through close collaboration, we assist customers in bringing drugs that profoundly impact human health to the market, focusing on patients and committed to improving their lives, thus promoting the development of the human health industry.